Ambrx Biopharma Inc (DELISTED) (AMAM:DL)
27.99
+0.01
(+0.04%)
USD |
NASDAQ |
Mar 06, 16:00
28.00
+0.01
(+0.04%)
After-Hours: 20:00
Ambrx Biopharma Cash from Operations (TTM): -57.70M for Sept. 30, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
September 30, 2023 | -57.70M |
June 30, 2023 | -54.60M |
Date | Value |
---|---|
March 31, 2023 | -55.98M |
December 31, 2022 | -68.68M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-68.68M
Minimum
Dec 2022
-54.60M
Maximum
Jun 2023
-59.24M
Average
-56.84M
Median
Cash from Operations (TTM) Benchmarks
Johnson & Johnson | 23.19B |
Axonics Inc | -10.47M |
Harpoon Therapeutics Inc (DELISTED) | -69.38M |
Merck & Co Inc | 14.76B |
RayzeBio inc (DELISTED) | -- |